IL-17A, IL-22, and IL-23 as Markers of Psoriasis Activity

Serum and tissue levels of IL-17 in different clinical subtypes of psoriasis

(2012) Senem Buyukkara Yilmaz et al.   ARCHIVES OF DERMATOLOGICAL RESEARCH

A comparison of serum inflammatory cytokines according to phenotype in patients with psoriasis

(2012) Y.B. Choe et al.   BRITISH JOURNAL OF DERMATOLOGY

Clear association between serum levels of adipokines and T-helper 17-related cytokines in patients with psoriasis

(2012) H. Nakajima et al.   CLINICAL AND EXPERIMENTAL DERMATOLOGY

Kinetics of circulating Th17 cytokines and adipokines in psoriasis patients

(2011) Hideki Nakajima et al.   ARCHIVES OF DERMATOLOGICAL RESEARCH

Interleukin (IL)-22, IL-17, IL-23, IL-8, vascular endothelial growth factor and tumour necrosis factor-α levels in patients with psoriasis before, during and after psoralen-ultraviolet A and narrowband ultraviolet B therapy

(2010) S. Coimbra et al.   BRITISH JOURNAL OF DERMATOLOGY

Serum cytokines and growth factor levels in Japanese patients with psoriasis

(2009) H. Takahashi et al.   CLINICAL AND EXPERIMENTAL DERMATOLOGY

The IL-23/Th17 Axis in the Immunopathogenesis of Psoriasis

(2009) Antonella Di Cesare et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Circulating Th17, Th22, and Th1 Cells Are Increased in Psoriasis

(2009) Shinji Kagami et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Interleukin-17 and Type 17 Helper T Cells

(2009) Pierre Miossec et al.   NEW ENGLAND JOURNAL OF MEDICINE

Psoriasis Vulgaris Lesions Contain Discrete Populations of Th1 and Th17 T Cells

(2008) Michelle A. Lowes et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Psoriasis Is Characterized by Accumulation of Immunostimulatory and Th1/Th17 Cell-Polarizing Myeloid Dendritic Cells

(2008) Lisa C. Zaba et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY